(Reuters) – Moderna Inc said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years.
The approval is for the vaccine’s two-dose series of 50 micro gram per dose, Moderna added.
(Reporting by Shivani Tanna in Bengaluru; Editing by Rashmi Aich)
Cavaliers feel better prepared for playoff stage after ’23 flop, face Magic in first-round series
Olympic organizers unveil strategy for using artificial intelligence in sports
UConn freshman Stephon Castle declares for NBA draft and becomes school’s second one-and-done player
Philadelphia 76ers player grades: Tyrese MaxeyNoah Dobson injury latest: Islanders star D-man skates ahead of Game 1 vs. Hurricanes
The Latest | Jury selection in Trump’s hush money trial shifts to picking alternates
The West African Sahel is becoming a drug smuggling corridor, UN warns, as seizures skyrocketAARP and NY Attorney General launch free shredding events across New York to combat identity theftHere are a few things to keep in mind when going to a licensed cannabis dispensary for the first time
Israel gave US last-minute warning about drone attack on Iran, Italian foreign minister says at G7
BNSF Railway says it didn’t know about asbestos that’s killed hundreds in Montana town
Soldiers who lost limbs in Gaza fighting are finding healing on Israel’s amputee soccer team
Emergency rooms refused to treat pregnant women, leaving one to miscarry in a lobby restroom
Nevada Supreme Court rulings hand setbacks to gun-right defenders and anti-abortion activists
